These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15171440)

  • 1. [Beta-blockers for protection against hypertensive target-organ damage].
    Takahashi F
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():583-6. PubMed ID: 15171440
    [No Abstract]   [Full Text] [Related]  

  • 2. [Management of hypertensive patients with cardiovascular damage].
    Tomiyama H; Takata Y; Yamashina A
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():612-6. PubMed ID: 15171444
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calcium channel blocker for protection against hypertensive target-organ damage].
    Fukuzawa J; Yao N; Sakuragi H; Baljinnyam E; Haneda T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():559-63. PubMed ID: 15171435
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diuretics for protection against hypertensive target-organ damage].
    Hashimoto S
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():574-7. PubMed ID: 15171438
    [No Abstract]   [Full Text] [Related]  

  • 5. [Control of blood pressure in prevention of hypertensive end-organ damage].
    Kido M; Ando K; Fujita T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 7. [ACE inhibitors for protection against hypertensive target-organ damage].
    Kihara M; Hashimoto T; Umemura S
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():564-8. PubMed ID: 15171436
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential mechanisms of stroke benefit favoring losartan in the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
    Devereux RB; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):443-57. PubMed ID: 17288698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group.
    Curr Hypertens Rep; 1999 Dec; 1(6):466-7. PubMed ID: 11041675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of the hypertensive heart].
    Middeke M
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S253-6. PubMed ID: 19085801
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treating essential hypertension. Are beta blockers still first choice?].
    Rahn KH
    MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta blockers in acute myocardial infarction.
    Jariwala PV; Lathi P; Ramesh G; Saha D; Chandra KS
    Indian Heart J; 2010; 62(2):148-53. PubMed ID: 21180308
    [No Abstract]   [Full Text] [Related]  

  • 15. What your blood pressure isn't revealing.
    Johns Hopkins Med Lett Health After 50; 2010 Nov; 22(9):4-5. PubMed ID: 21066836
    [No Abstract]   [Full Text] [Related]  

  • 16. Setting up a beta-blocker protocol to prevent cardiac complications.
    Mathias JM
    OR Manager; 2005 May; 21(5):1, 8-10. PubMed ID: 15945469
    [No Abstract]   [Full Text] [Related]  

  • 17. [LIFE study proves preventive action. With losartan to do even more against stroke].
    Baumgart P
    MMW Fortschr Med; 2003; 145 Suppl 1():7-8. PubMed ID: 12958796
    [No Abstract]   [Full Text] [Related]  

  • 18. [Impact of antihypertensive treatment on target organs].
    Fregoso Padilla J
    Arch Cardiol Mex; 2002; 72 Suppl 1():S58-63. PubMed ID: 12001872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent intervention studies with antihypertensive drugs and their influence on guidelines].
    Rahn KH
    Med Klin (Munich); 2003 Dec; 98(12):771-5. PubMed ID: 14685679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I; Edes I
    Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.